Amyloid Beta-directed Antibodies
- Name
- Amyloid Beta-directed Antibodies
- Accession Number
- DBCAT005532
- Description
Monoclonal antibodies directed towards amyloid beta plaques.
- Drugs
Drug Drug Description Aducanumab A monoclonal antibody indicated in the treatment of Alzheimer's disease. Lecanemab An amyloid beta-targeting antibody used to treat Alzheimer’s Disease in patients with mild cognitive impairment or mild dementia with a known amyloid beta pathology. - Drugs & Drug Targets
Drug Target Type Aducanumab Amyloid beta A4 protein target Lecanemab Amyloid beta A4 protein target